CClinicalTrials.gg
CompletedNCT07088770TMP ProjectUpdated Feb 18, 2026

TechMPower: Advancing HIV/SUD Care and Service Delivery for People in Re-entry

An interventional study of Community Coalition CLS Workgroup/Network of Providers and Tech-mediated Training and Service Delivery in HIV (Human Immunodeficiency Virus) and Substance Abuse Disorder, sponsored by Columbia University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by Columbia University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2024, registered Jul 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical study in one NY county is to pilot and refine implementation strategies aimed at improving delivery and uptake of evidence-based practices (EBPs) for HIV prevention/treatment and substance use disorder (SUD) care among incarcerated individuals approaching release with or at risk for HIV and SUD.

The main questions it aims to answer are:

  1. How feasible and acceptable are the TechMPower implementation strategies (community coalition workgroups, multidisciplinary implementation team with champion, and tech-mediated training/service delivery with peer navigation) in real-world carceral and reentry settings?
  2. To what extent do these strategies improve delivery and uptake of HIV testing with self-testing (HST), pre-exposure prophylaxis (PrEP)/antiretroviral treatment (ART), medications for opioids use disorder (MOUD), and overdose education and naloxone distribution (OEND)?
  3. What are the preliminary cost estimates for the implementation strategies and EBPs to inform the larger trial to follow in NY and NJ?
  4. What are the preliminary impacts on individual-level outcomes such as HIV testing, linkage to care, and SUD treatment initiation?

Our specific aims for the Phase I protocol presented here is conducted in one county (Ulster County) with a sample (n=50) of detained (prisoners) in their county jail are presented here:

  • R61 \| Aim 1: Evaluate \ preliminary effectiveness of TechMPower, using mixed methods and a pre-/post-evaluation design, on increasing reach of the EBPs resulting in the following outcomes: (1) SUD and HIV screenings (pre-/post-release); and (2) linkage to SUD prevention/care (MOUD, OEND); and (3) linkage to HIV prevention/care (applying a status-neutral approach) with community service providers post-release. (Effectiveness).
  • R61 \| Aim 2: Identify how adoption/feasibility, implementation/fidelity and sustainability/maintenance of TechMPower may impact effectiveness of TechMPower outcomes as described in Aim 1 in one (Ulster County) jail using surveys of Implementation Team, jail staff and other key stakeholders. (Implementation)
  • R61 \| Aim 3: Use implementation mapping to adapt implementation strategies for R33 phase. (Implementation)
Read the detailed description

HIV prevalence in correctional facilities in the US is about five times greater than in the general population and about 14% of people living with HIV (PLWH) experience incarceration/release every year and 15% of those incarcerated do not know their HIV status. Over 50,000 people are incarcerated in New York state and 1-2% are estimated to be PLWH. Similarly, substance use disorder (SUD) is highly prevalent among criminal-legal system (CLS)-involved people, with an estimated 70-80% of US jail detainees having a SUD are at high risk of relapse, overdose-related mortality and HIV infection post-release. Intervening during incarceration provides an opportunity to address HIV care in hard-to-reach individuals, though more robust interventions and staff training is needed to improve care continuity. Increasing point-of-care rapid testing would maximize HIV detection and results receipt among people in jails, and prepare them with needed knowledge and skills post-release.

To fill this gap, the investigators propose a Regional Research Hub (RRH) and 2-phase, Hybrid Type II effectiveness/implementation study to evaluate the effectiveness of TechMPower, an intervention that bundles implementation strategies to increase delivery of evidence-based intervention (EBPs) to prevent adverse HIV-related (new infection, untreated HIV) and SUD-related outcomes (fatal and non-fatal overdose) among a sample of individuals (n=1200) in 6 New York and New Jersey State County jails. In the first phase submitted in this IRB protocol, the researchers will pilot TechMPower to prepare for the phase two full R33 trial, informed by PRISM/RE-AIM and the health equity framework, by recruiting in one NYS county jail (n=50) and an existing HEALing Communities Study coalition workgroup to evaluate the training on and implementation of the selected EBPs required as standard of care in jails. This record contains the R61 pilot portion.

Researchers will compare outcomes before and after implementation of the strategy bundle to see if TechMPower improves reach, adoption, implementation fidelity, and sustainability of integrated HIV/SUD services.

Participants incarcerated (N=50) will:

  1. Complete baseline and 3-month follow-up surveys on HIV/SUD behaviors and care engagement
  2. Participate in up to 60-minute qualitative interviews (subset N=8)
  3. Receive potential HIV/STI testing, referrals to prevention/treatment, and linkage services including peer navigation enhanced case management (NCM)
  4. Receive HIV self-test kit and Naloxone upon release

Stakeholder participants (N=20) will:

  1. Complete baseline and 3-month follow-up surveys on HIV/SUD behaviors and care engagement
  2. Participate in up to 60-minute qualitative interviews (subset N=8)
  3. Receive training in HIV and SUD screening and treatment referral (SBIRT), HST and OEND, person-centered approach to care linkage; tech-mediated training and service delivery; and in NCM
  4. Participate in coalition workgroup, implementation team and implementation of NCM
02

Conditions studied

  • HIV (Human Immunodeficiency Virus)
  • Substance Abuse Disorder

Keywords

  • People incarcerated in re-entry
  • HIV testing
  • Screening, brief intervention, and referral to treatment
  • Implementation strategies
  • Implementation team with champion
  • Navigation case management
  • Coalition
  • Techmediated
03

In context

Acquired Immunodeficiency Syndrome

2,040 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 272 are open to participants now.

This study's enrollment of 65 is below the median of 105 across 1,543 interventional studies indexed under Acquired Immunodeficiency Syndrome.

Browse Acquired Immunodeficiency Syndrome studies →

Lead sponsor

Columbia University is the lead sponsor of 1,103 studies on the registry; 193 are open to participants now.

Of its 172 completed or terminated interventional studies of FDA-regulated products, 142 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ≥18 years old
  • speaks and understands English
  • report using any illicit drug, in the six months prior to incarceration
  • report having had condomless receptive and/or insertive vaginal and/or anal sex without either condom use, AND/OR report another HIV risk in the six months prior to incarceration (i.e. shared syringes, STI+)D
  • likely to be released in the next 1-3 months

Exclusion criteria

Exclusion Criteria:

  • evidence of significant psychiatric or cognitive impairment that would limit effective participation as confirmed during informed consent assessed during informed consent or confirmed by the MacArthur Competence Assessment Tool
  • not fluent in English
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    TechMPower Implementation Strategies

    TechMPower applies evidence-based Implementation Strategies, including: A) data-driven, Community Coalitions and criminal legal system (CLS) focused workgroup informed by the HEALing Communities Study (HCS) Communities That HEAL(CTH intervention); B) Implementation Team led by champions; C) training on optimal person-centered service delivery for service providers/organizations; and D) tech-mediated service delivery, technical assistance, and training to increase: 1) HIV screening/testing via self-testing; 2) SUD screening, brief interview and referral to treatment (SBIRT); and 3) access to and uptake of biomedical HIV and SUD prevention and treatment (PrEP/PEP/ART); overdose education/naloxone distribution \[OEND\], opioid use disorder medication \[MOUD\]) delivered through 4) hybrid linkage (telehealth, face-to-face) to services via Navigation Enhanced Case Management (NCM).

    Behavioral: Community Coalition CLS Workgroup/Network of Providers · Behavioral: Tech-mediated Training and Service Delivery · Behavioral: Multidisciplinary Implementation Team with Champion · Behavioral: Tech-mediated Peer Navigation Enhanced Case management (NCM)

Interventions

  • BehavioralCommunity Coalition CLS Workgroup/Network of Providers

    Community Coalition/Network of Providers TechMPower forms the foundation of community engagement in this approach, with membership including PLWH and SUD, sheriffs, within-jail staff, community service providers or other partners who are able to advance the adoption of EBPs within jail and service settings. All coalitions are trained and prepared to drive a planning process at the local level for efficient identification and allocation of resources needed to link people from CLS to a network of community providers for HIV and SUD care and retention. Community coalitions integrate evidence-based (ERIC) strategies: Build coalition; Promote network weaving; Identify/train champions; Conduct consensus discussions that support needed services.

  • BehavioralTech-mediated Training and Service Delivery

    Researchers will train all staff, healthcare providers and peer navigators to recognize and reduce stigma in CLS and healthcare settings using a training program informed by MPI Frye and colleagues in the CHHANGE (MH102182-01) intervention, which developed an anti-intersectional stigma training program for CBOs and offers comprehensive training to healthcare and social service organizations. Additionally, researchers will train staff and support protocol enhancements as needed to utilize tech mediated service delivery for NCM in-reach and services coordination in the community. These integrate 5 evidence-based (ERIC) implementation strategies: promote consultation; provide clinical/technical supervision; centralize technical assistance; change physical structure and equipment.

  • BehavioralMultidisciplinary Implementation Team with Champion

    The multidisciplinary Implementation Team will be comprised of a correctional health nurse, social worker and discharge planner or counselor and corrections officer from the jail. A representative from the community coalition and peer and case manager from NCM will join the team using a tech-mediated platform for conducting the training and for on-going weekly case conferencing addressing system and client level barriers and service planning. The role of the champion from the correctional setting will be to convene meetings focused on fidelity to the intervention components, engagement in shared problem-solving and mediation of administrative issues that may inhibit effective implementation of TechMPower. The champion and implementation team may request technical assistance (TA) or implementation facilitation at any point during implementation. This TA may be provided by the investigative team or outside providers from federal programs.

  • BehavioralTech-mediated Peer Navigation Enhanced Case management (NCM)

    Navigation-Enhanced Case Management (NCM) uses Project START, a CDC best evidence intervention as its HIV risk reduction framework. Prior to release, a case manager and peer navigator via telehealth and in-person provide discharge planning and patient education and serves as a liaison to the courts. After release, patient navigators facilitate reentry into community care and provide referrals to HIV medical and SUD care as appropriate (e.g., ART, PrEP, MOUD) and assistance with food, housing, transportation, employment, substance dependence, mental health treatment, and legal issues. TechMPower planned to enhance tracking of linkage during NCM services by integrating reporting along with a web-based platform that tracks assignment of providers and peers and follows for 6 months to capture PRISM linkage and retention in MOUD, HIV and ancillary care.

06

What researchers measure

Primary outcomes

  1. Number of people incarcerated who have received an HIV test

    This is to measure HIV testing (including self-testing) at jail. The number of participants that report in survey at least 1 testing will be tallied. Aggregate reporting on testing from facility will be captured for triangulation.

    Time frame: Baseline and 3 months follow-up

  2. Number of people detained screened for SBIRT

    This is to measure the feasibility, efficacy of Screening, Brief Intervention and Referral to treatment (SBIRT) for SUD at jail. The number of participants that report in survey receiving SBIRT will be tallied. Aggregate reporting on SBIRT from facility will be captured for triangulation.

    Time frame: Baseline and 3 months follow-up

  3. HIV care access & utilization/ART Use/adherence/viral load/CD4 count

    Service Use Measure: at least one visit to HIV-focused medical at clinic post release. The number of participants that report in surveys receiving HIV treatment will be tallied. Aggregate reporting on HIV treatment from facility referrals will be captured for triangulation.

    Time frame: 3-month following pos test result, pre- post release

  4. Average PrEP oral daily/injectable/episodic PrEP captured in records/chart review; ACASI self-report

    This is to measure PrEP use, adherence \& discontinuation

    Time frame: Baseline and 3 months follow-up

  5. PEP uptake rate

    This is to measure PEP use by seeing the uptake: starter pack \& full treatment provision/fulfillment and adherence, PEP to PrEP transition

    Time frame: Baseline and 3 months follow-up

Secondary outcomes

  1. Number of clients referred and assessed for NCM

    This is to measure the feasibility of Navigation Enhanced Case Management (NCM). The number of participants that report in survey receiving NCM will be tallied. Aggregate reporting on NCM service delivery will be captured for triangulation.

    Time frame: Baseline and 6 months

  2. Number of people incarcerated receiving OEND

    This is to measure the Overdose education and Naloxone Distribution (OEND) feasibility at jail. The number of participants that report in survey receiving OEND will be tallied. Aggregate reporting on OEND service delivery from facility will be captured for triangulation.

    Time frame: Baseline and 3 months follow-up

  3. Number of staff receiving training on TechMPower integrated SUD/HIV service delivery

    This is to measure the feasibility of TechMPower techmediated training and HIV/SUD integrated service delivery. This is reported on surveys and aggregate reporting on techmediated training attendance logs for triangulation.

    Time frame: Baseline and 6 months follow up

07

Study locations

1 site
  • Ulster County Jail
    Kingston, New York 12401, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07088770
Lead sponsor
Columbia University
Collaborators
National Institute on Drug Abuse (NIDA), University of Pennsylvania
Responsible party
Timothy Hunt (Associate Research Scientist in the Faculty of Social Work, Columbia University) — Principal investigator
First posted
Jul 28, 2025
Start date
Nov 22, 2024
Primary completion
Sep 30, 2025
Completion
Sep 30, 2025
Last update
Feb 18, 2026

Study contacts

Timothy L Hunt, MSW, PhD
principal investigator · Columbia University
Victoria A Frye, MPH, DrPH
principal investigator · Columbia University
Nabila El-Bassel, PhD
principal investigator · Columbia University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion